The Italian government has recently adopted the Council of Europe Recommendation no.R (95)15 on GMP (Good Manufacturing Practice) and quality control of blood components. However, there is still discussion as to which assays are appropriate for the quality control of plateletpheresis concentrate, PBSC concentrate and granulocyte concentrate. The main issues of programs to ensure the delivery of high quality products are discussed.
Council of Europe:Guide to the Preparation, Use and Quality Assurance of Blood Components.Strasbourg, Council of Europe Press, 1996.
2.
MurphyS., RebullaP., BertoliniF.. In vitro Assessment of the quality of stored platelet concentrates.Transf Med Rew1994; 8: 29–36.
3.
SeghatchianJ., KrailadsiriP.The platelet storage lesion.Transf Med Rew1997; 11: 130–44.
4.
HogmanC.Routine quality assurance requirements for aphe-resed platelets.Transfus Sci1993; 14: 85–8.
5.
DavisJ.M., ScherpersK.G.Quality control of hemopoietic progenitor cell products. In: BrecherM.E., LaskyL.C., SacherR.A., IssitL.A., eds. Hematopoietic progenitor cells: processing, standards and practice.Bethesda: American Association of Blood Banks,1995: 159–81.
6.
BenderJ.G., ToL.B., WilliamsS.. Defining a therapeutic dose of peripheral blood stem cells.J Hematother1992; 1: 329–35.
7.
SutherlandD.R., AndersonL., KeeneyM.. The ISHAGE guidelines for CD 34+ cell determination by flow cytometry.J Hematother1996; 3: 213–26.
8.
Strauss RG Clinical perspectives of granulocyte transfusion: efficacy to date.J Clin Apheresis1995; 10: 114–8.
9.
PriceT.H.Blood Center perspective of granulocyte transfusion: future applications.J Clin Apheresis1995; 10: 119–23.
